[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-338564-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-338564-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","challenges-following-crs-and-hipec-surgery-in-cancer-patients-with-peritoneal-metastasis-a-comprehensive-review-of-clinical-outcomes","Challenges following CRS and HIPEC surgery in cancer patients with peritoneal metastasis - a comprehensive review of clinical outcomes","","Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are reviewed as modern treatments for advanced cancer patients with peritoneal metastasis (PM). The review examines side effects and complications after CRS + HIPEC, organizing events by surgical, chemotherapy, anesthetic, gastrointestinal, organ, and systemic categories. It summarizes the incidence, frequency, types, and risk factors of acute complications and stresses careful patient selection, precise surgical technique, and thorough intraoperative care. Interdisciplinary collaboration is highlighted to improve clinical safety and efficacy.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/challenges-following-crs-and-hipec-surgery-in-cancer-patients-with-peritoneal-metastasis-a-comprehensive-review-of-clinical-outcomes/338564/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/challenges-following-crs-and-hipec-surgery-in-cancer-patients-with-peritoneal-metastasis-a-comprehensive-review-of-clinical-outcomes/338564.png","ImageObject",300,407,{"name":42,"@type":43},"Genevieve","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-14","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main goal of CRS + HIPEC for patients with peritoneal metastasis?","Question",{"text":63,"@type":64},"CRS + HIPEC aims to improve survival by surgically reducing visible tumor burden and eradicating microscopic disease using heated chemotherapy delivered into the abdominal cavity.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does the review categorize complications after CRS + HIPEC?",{"text":68,"@type":64},"Complications are separated into categories including surgical-related, chemotherapy-related, anesthetic-related, gastrointestinal, organ, and systemic complications, based on frequency, risk factors, and effects on outcomes.",{"name":70,"@type":61,"acceptedAnswer":71},"Which factors does the review emphasize to reduce or manage risks?",{"text":72,"@type":64},"It emphasizes careful patient selection criteria, precise surgical technique, and thorough intraoperative care, along with interdisciplinary collaboration to improve safety and efficacy.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},338564,1790342891,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},1374391974585,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","TYPE Review  \nPUBLISHED 02 December 2024 DOI 10.3389/fsurg.2024.1498529  \nEDITED BY  \nBaohong Yang,  \nZhengzhou University, China  \nREVIEWED BY  \nXiangpo Pantas, Zhengzhou University, China Haiyan Chou,  \nWeifang People’s Hospital, China  \n*CORRESPONDENCE  \nMehdi Karimi  \n [karimi9010@gmail.com](karimi9010@gmail.com)  \nRECEIVED 19 September 2024  \nACCEPTED 18 November 2024  \nPUBLISHED 02 December 2024  \nCITATION  \nKarimi M, Shirsalimi N and Sedighi E (2024) Challenges following CRS and HIPEC surgery in cancer patients with peritoneal metastasis: a comprehensive review of clinical outcomes. Front. Surg. 11:1498529 .  \ndoi: 10.3389/fsurg.2024.1498529  \nCOPYRIGHT  \n© 2024 Karimi, Shirsalimi and Sedighi. This isan open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nChallenges following CRS and HIPEC surgery in cancer patients with peritoneal metastasis: a comprehensive review of clinical outcomes  \nMehdi Karimi1*, Niyousha Shirsalimi2 and Eshagh Sedighi3  \n1Faculty of Medicine, Bogomolets National Medical University (NMU), Kyiv, Ukraine, 2Faculty of Medicine, Hamadan University of Medical Science (UMSHA), Hamadan, Iran, 3Department of Veterinary Medicine, Islamic Azad University Branch of Urmia, Urmia, Iran  \nCytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) are a pair of relatively modern therapeutic surgical methods in advanced cancerous patients with peritoneal metastasis (PM) . The goal of CRS + HIPEC is treatment or to improve survival outcomes, which are linked to high morbidity side effects and complications, even with their possible advantages. Surgical-related, chemotherapy-related, anesthetic-related, gastrointestinal, organs and systemic complications are the categories into which complications are separated according to frequency, risk factors, and effect on patient outcomes. In this narrative review of the literature, the side effects and complications of HIPEC + CRS in cancer patients with PM are examined. The present knowledge on the incidence, frequency, kinds, and risk factors of acute complications following CRS + HIPEC is summarized in this study. This review emphasizes the need for careful patient selection criteria, precise surgical technique, and thorough intraoperative care to reduce or manage these risks. Moreover, it highlights the need for interdisciplinary collaboration in treating these patients. This study aims to know these complications, improve clinical practice, and guide future studies to increase the safety and efﬁcacy of CRS + HIPEC in treating metastatic colorectal cancer.  \nKEYWORDS  \ncytoreductive surgery, hyperthermic intraperitoneal chemotherapy, chemotherapy, peritoneal metastasis, surgical oncology, surgery, Malignancy, cancer  \nAbbreviations  \nCRS, cytoreductive surgery; HIPEC, hyperthermic intraperitoneal chemotherapy; PM, peritoneal metastasis; PCI, peritoneal carcinomatosis index; QoL, quality-of-life; AKI, acute kidney injury; CKD, chronic kidney disease.  \nFrontiers in Surgery 01 [frontiersin.org](frontiersin.org)  \nKarimi et al. 10.3389/fsurg.2024.1498529  \nGRAPHICAL ABSTRACT  \n1 Introduction  \nCytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are paired with modern surgical therapeutic methods to treat metastatic cancer, which is spread to the abdominal cavity and its organ and structure. CRS + HIPEC is aimed at improving survival in patients with peritoneal metastasis (PM) (1) . PM, a typical progression in various abdominal cancers, signiﬁcantly diminishes patient prognosis and quality-of-life (QoL) (2, 3) . Traditional systemic thera","cbCaio7OL54rZg9n","https://ap.wps.com/l/cbCaio7OL54rZg9n","pdf",12822306,18,"English","# Introduction\n## Patient selection and treatment rationale\n## Overview of complications and risk categories","[{\"question\":\"What is the main goal of CRS + HIPEC for patients with peritoneal metastasis?\",\"answer\":\"CRS + HIPEC aims to improve survival by surgically reducing visible tumor burden and eradicating microscopic disease using heated chemotherapy delivered into the abdominal cavity.\"},{\"question\":\"How does the review categorize complications after CRS + HIPEC?\",\"answer\":\"Complications are separated into categories including surgical-related, chemotherapy-related, anesthetic-related, gastrointestinal, organ, and systemic complications, based on frequency, risk factors, and effects on outcomes.\"},{\"question\":\"Which factors does the review emphasize to reduce or manage risks?\",\"answer\":\"It emphasizes careful patient selection criteria, precise surgical technique, and thorough intraoperative care, along with interdisciplinary collaboration to improve safety and efficacy.\"}]","Challenges following CRS and HIPEC surgery in cancer patients with peritoneal metastasis - a comprehensive review of clinical outcomes | PDF",1790024268,45,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/99ed489cfe9ed4972cd4e1e8ff680171.webp",983,1390,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2af37681b148f91846df5cea4b43ad75.webp",982,1388,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8309aab06b7dd1ac0034cace01210516.webp",981,1387,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b1959867bc0e0c366c398a9dbd29d886.webp",980,1385]